Biosecurity

J&J Pasritamig Shows Strong Activity in Prostate Cancer Trial
Biotech & Bioprocessing J&J Pasritamig Shows Strong Activity in Prostate Cancer Trial

The clinical landscape for treating metastatic castration-resistant prostate cancer is undergoing a fundamental transformation as researchers pivot from conventional hormonal therapies toward high-precision immunotherapy. While androgen receptor pathway inhibitors have long served as the backbone

How Is Rapid Courier Improving Ghana’s Medical Waste Safety?
Biotech & Bioprocessing How Is Rapid Courier Improving Ghana’s Medical Waste Safety?

The persistent challenge of hospital-acquired infections remains a critical hurdle for healthcare systems across West Africa, often stemming from the inadequate containment of hazardous clinical materials. In a landscape where the safe disposal of infectious waste can determine the success of

EU Proposes New Policies to Tackle Chronic Medicine Shortages
Biotech & Bioprocessing EU Proposes New Policies to Tackle Chronic Medicine Shortages

The silent struggle within European pharmacies has reached a tipping point where the simple act of filling a basic prescription for antibiotics or painkillers has become a logistical marathon for healthcare providers and a source of deep anxiety for patients. For too long, the stability of the

Can Antibody Engineering Finally Defeat Glioblastoma?
Biotech & Bioprocessing Can Antibody Engineering Finally Defeat Glioblastoma?

The relentless progression of oncology over the past several decades has fundamentally altered the prognosis for many once-terminal cancers, yet glioblastoma remains a stubborn outlier in this narrative of medical triumph. While the integration of immune checkpoint inhibitors and targeted

Lilly Trial Validates Dual Therapy for Psoriasis and Obesity
Biotech & Bioprocessing Lilly Trial Validates Dual Therapy for Psoriasis and Obesity

The long-standing clinical practice of treating chronic inflammatory diseases and metabolic disorders as entirely separate medical concerns is currently undergoing a radical transformation as new research underscores their deep biological interconnectedness. Traditionally, the medical community has

EU Approves GSK’s Twice-Yearly Asthma and Sinus Treatment
Biotech & Bioprocessing EU Approves GSK’s Twice-Yearly Asthma and Sinus Treatment

Managing severe, persistent respiratory conditions often feels like a relentless battle, with frequent treatments and the constant threat of debilitating flare-ups dictating the rhythm of daily life. For millions, conditions like severe asthma and chronic rhinosinusitis with nasal polyps represent

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later